|
| Press Releases |
|
 |
|
| Wednesday, February 26, 2014 |
|
|
Cytokinetics Announces Closing of its Public Offering of Common Stock and Exercise of Option to Purchase Additional Shares |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today the closing of its previously announced underwritten public offering of 4,375,000 shares of its common stock, as well as 656,250 additional shares of its common stock pursuant to the full exercise of the underwriters' option to purchase additional shares. more info >> |
|
| Friday, February 21, 2014 |
|
|
Cytokinetics Announces pricing of $35.0 Million Public Offering of Common Stock |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today the pricing of its previously announced underwritten public offering of 4,375,000 shares of its common stock at a price to the public of $8.00 per share. more info >> |
|
| Thursday, February 20, 2014 |
|
|
Cytokinetics Announces Proposed Public Offering of Common Stock |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. more info >> |
|
| Friday, February 7, 2014 |
|
|
Cytokinetics, Incorporated Reports Fourth Quarter 2013 Financial Results |
| Cytokinetics, Incorporated (Nasdaq: CYTK) reported total revenues of $24.3 million for the fourth quarter of 2013, compared to $2.2 million during the same period in 2012. Net income for the fourth quarter was $6.5 million, or $0.22 per basic share and $0.21 per diluted share. more info >> |
|
| Wednesday, February 5, 2014 |
|
|
Cytokinetics to Present at Upcoming Healthcare Conferences |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that members of its management team are scheduled to participate at the following healthcare conferences. more info >> |
|
| Friday, January 24, 2014 |
|
|
Cytokinetics to Announce Fourth Quarter Results on February 6, 2014 |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that it is scheduled to report fourth quarter results on Thursday, February 6, 2014 at 4:00 PM Eastern Time. more info >> |
|
| Monday, January 13, 2014 |
|
|
Cytokinetics Provides Updates Regarding Clinical Development Program for Omecamtiv Mecarbil |
| Cytokinetics, Incorporated (Nasdaq: CYTK) provided updates today regarding COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure) and other progress in the development of omecamtiv mecarbil. more info >> |
|
| Tuesday, December 10, 2013 |
|
|
Cytokinetics Announces Results from First-Time-In-Humans Clinical Trial of CK-2127107 at Conference of the Society on Sarcopenia, Cachexia and Wasting Disorders |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that the results from a first-time-in-humans clinical trial of CK-2127107 in healthy male volunteers were presented during a Late Breaking Clinical Trials session at the 7th International Conference of the Society on Sarcopenia, Cachexia and Wasting Disorders in Kobe, Japan. more info >> |
|
| Monday, December 9, 2013 |
|
|
Cytokinetics Announces Presentation Providing Update on BENEFIT-ALS at International Symposium on ALS/MND |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that a platform presentation of data from BENEFIT-ALS (Blinded Evaluation of Neuromuscular Effects and Functional Improvement with Tirasemtiv in ALS) was given at the 24th International Symposium on ALS/MND on December 7, 2013 in Milan, Italy. more info >> |
|
| Wednesday, December 4, 2013 |
|
|
Cytokinetics to Present Data Related to Skeletal Muscle Activators at Conference of Society on Sarcopenia, Cachexia and Wasting Disorders |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that two presentations, relating to its fast skeletal muscle troponin activators, are scheduled to be presented at the 7th International Conference of the Society on Sarcopenia, Cachexia and Wasting Disorders from December 9-11, 2013 in Kobe, Japan. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Cambridge Isotope Laboratories (CIL) Shows Long-Term Commitment to Xenia, Ohio, Facility With New Land Purchase
Apr 25, 2024 21:00 HKT/SGT
|
|
|
黑桃资本向香港红十字会捐赠艺术珠宝收藏品
Apr 25, 2024 20:53 HKT/SGT
|
|
|
黑桃資本向香港紅十字會捐贈藝術珠寶收藏品
Apr 25, 2024 20:48 HKT/SGT
|
|
|
Black Spade Donates Art and Jewellery Collection To Hong Kong Red Cross
Apr 25, 2024 20:40 HKT/SGT
|
|
|
Q2 Metals Announces Assay Results from Its 2023 Inaugural Drill Program at the Mia Lithium Property, James Bay Territory, Quebec, Canada
Apr 25, 2024 19:09 HKT/SGT
|
|
|
【最新弹床好去处推介】将军澳中心x Kiztopia星际弹游太空站
Apr 25, 2024 18:05 HKT/SGT
|
|
|
【最新彈床好去處推介】將軍澳中心x Kiztopia星際彈遊太空站
Apr 25, 2024 18:00 HKT/SGT
|
|
|
Mazda Production and Sales Results for March 2024 and for April 2023 through March 2024
Apr 25, 2024 18:21 JST
|
|
|
MHI Begins Operation of SOEC Test Module the Next-Generation High-Efficiency Hydrogen Production Technology at Takasago Hydrogen Park
Apr 25, 2024 17:45 JST
|
|
|
トヨタ、2023年度 販売・生産・輸出実績を発表
Apr 25, 2024 16:16: JST
|
|
|
8 in 10 Singapore businesses experienced more change in last 4 years than previous two decades: HubSpot Research
Apr 25, 2024 16:00 HKT/SGT
|
|
|
GAC Honda to Begin Sales of All-new e:NP2, the Second Model of e:N Series
Apr 25, 2024 16:50 JST
|
|
|
Toyota Exhibiting at Beijing Motor Show 2024
Apr 25, 2024 16:25 JST
|
|
|
中信国际电讯CPC成为博通 (Broadcom) 战略合作伙伴 荣登VMware 云服务供应商 (VCSP) - Pinnacle更高合作级别位置
Apr 25, 2024 13:22 HKT/SGT
|
|
|
中信國際電訊CPC成為博通 (Broadcom) 戰略合作夥伴 榮登VMware 雲服務供應商 (VCSP) - Pinnacle最高合作級別位置
Apr 25, 2024 13:17 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
